Rao spoke with Cardiovascular Business at ACC.23 to detail some of SCAI's biggest accomplishments from the last year. 

Medtronic launched its MRI Care Pathway, a new system that can streamline the process of completing MRI scans for patients with compatible cardiac devices.

The interventional cardiologist is now working with vendor Supira Medical to help advance the company's next-generation percutaneous ventricular assist device.

This latest recall is due to a heightened risk that the devices will stop working with no warning. There have been 42 customer complaints reported so far. 

SCAI President Sunil Rao, MD, spoke with us about some of the key interventional cardiology studies presented at ACC.23 in New Orleans. 

According to a new study of more than 119,000 hospitalizations, the costs associated with TAVR are far from consistent. 

The recall, announced by the FDA, includes multiple lots of dabigatran etexilate capsules.

Atul Verma, MD, director of cardiology at McGill University Health Centre in Montreal, explained why the late-breaking PULSED-AF trial data on Medtronic’s pulsed-field ablation technology is so important for cardiologists. 

In some cases, certain classes of anti-amyloid beta (Aβ) drugs resulted in individuals’ brain volume decreasing more rapidly while using the drug than they would have if they had not received treatment at all. 

A team of experts with the University of Maryland School of Medicine recently presented ChatGPT with a set of questions relative to breast cancer screening recommendations to determine whether the program could reliably offer appropriate guidance.